HIV-1 latency reversal agent boosting is not limited by opioid use.
Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A.
Lilie T, et al. Among authors: bouzy j.
medRxiv [Preprint]. 2024 Jun 4:2023.05.26.23290576. doi: 10.1101/2023.05.26.23290576.
medRxiv. 2024.
PMID: 37398278
Free PMC article.
Updated.
Preprint.